why choose us

Clinical Trials Search

Showing 9,890 of 132,656 result(s)
R-2487 in Patients With Rheumatoid Arthritis

Status: Completed

Condition: Arthritis, Rheumatoid

Interventions: Probiotic

Date: 2023-07-18

Increasing Food Literacy in Preschoolers to Reduce Obesity Risk

Status: Completed

Condition: Food Preferences

Interventions: The Healthy Eating (HE) curriculum is designed to provide children with skills needed to develop healthy eating habits.
Each lesson builds upon t

Date: 2023-07-18

A Study of LY3871801 in Healthy Asian and Non-Asian Participants

Status: ACTIVE_NOT_RECRUITING

Condition: Healthy

Interventions: Administered orally.

Date: 2023-07-18

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Status: Completed

Condition: Non Muscle Invasive Bladder Cancer

Interventions: QUILT-2.005 phase 1b (NCT02138734) was an open-label, dose-escalation, multicenter study of intravesical Bacillus Calmette-Guerin (BCG) plus N-803 in

Date: 2023-07-18

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy

Status: Completed

Condition: Macular Degeneration, Age Related

Interventions: Spectralis is a scanning laser ophthalmoscope which uses a blue light excitation wavelength of 488nm and a 500nm barrier filter to produce FAF images.

Date: 2023-07-18

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip

Status: Completed

Condition: Kidney Transplant; Complications

Interventions: We will test the study hypothesis in a single center, matched (1:1 fashion) pilot study of Letermovir 480 mg once daily versus historically matched AA

Date: 2023-07-18

Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: Penguin cold cap: administered 60 minutes prior to melphalan infusion and continue for 5 hours after melphalan infusion start time, for a total of 6 h

Date: 2023-07-18

Naltrexone and Propranolol Combined With Immunotherapy

Status: Completed

Condition: Advanced Melanoma

Interventions: Propranolol will be administered to patients in all cohorts.

Date: 2023-07-18

NS-089;NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Status: NOT_YET_RECRUITING

Condition: Duchenne Muscular Dystrophy

Interventions:

Cohort 1:

Part 1 Dose Level 1-3: a 4-week Treatment Phase at each treatment dose level

Part 2 Single Dose Level: a 24-week Treatment Ph

Date: 2023-07-18

Monitoring Postprandial Glycemia in Fruit Snacks

Status: Completed

Condition: Blood Glucose

Interventions: Fruit snacks with original level of sugar

Date: 2023-07-18